Business
Harvest One Announces New Satipharm Distribution Agreement
Harvest One Announces New Satipharm Distribution Agreement Canada NewsWire VANCO...
About this update from Delivra Health Brands Inc
[{"type":"text","content":"\n\n\n\nHarvest One Announces New Satipharm Distribution Agreement\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, March 28, 2019\n\n\n\nAgreement with Health House for distribution of Satipharm CBD Gelpell® Capsules throughout Australia, New Zealand and Asia.\n VANCOUVER, March 28, 2019 /CNW/ - Harvest One Cannabis Inc. (\"Harvest One\" or the \"Company\") (TSXV: HVT; OTCQX: HRVOF), through it's wholly-owned subsidiary Satipharm Ltd. (\"Satipharm\") today announced that it has entered into an agreement to become a supplier to the renowned medicinal cannabis wholesale & distribution business, Health House International Pty Ltd (\"Health House\").\n\n \n \n\n \nUnder the terms of the agreement, Harvest One will supply Health House with Satipharm CBD 50mg Gelpell® capsules. The product will continue its availability in Australia, while expanding distribution to New Zealand and Asia where and when legal.\nUnder the agreement, Health House distribute Satipharm's medicinal cannabis products to their existing network of pharmacies while also supporting healthcare professionals with Satipharm product information. Health House International are one of the major wholesalers to Australian pharmacies for medicinal cannabis. In May 2017 they imported one of the first legal international medicinal cannabis shipments into Australia. \n\"This agreement with Health House increases the availability of our Satipharm CBD 50mg Gelpell® capsules across Australia, while expanding Satipharm's medical cannabis distribution territories to New Zealand and Asia where and when legal\" said Grant Froese, CEO of Harvest One. \"We are committed to delivering the highest quality cannabinoid-based products globally. As further regions become available, we will endeavor to put agreements in place that will allow us to meet the needs of our patients.\"\nPharmacist, CEO and founder of Health House Paul Mavor said: \"The addition of Satipharm's 50mg Gelpell® capsules to our range allows us to provide c...